Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Fujian Province
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference197 articles.
1. Ribociclib inhibits P-gp-mediated multidrug resistance in human epidermoid carcinoma cells;Zhang;Front Pharmacol,2022
2. Targeting breast cancer resistance protein (BCRP/ABCG2): functional inhibitors and expression modulators;Zattoni;Eur J Med Chem,2022
3. CDK6–PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells;Zhang;Mol Cancer,2022
4. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer;Zhang;Mol Cancer,2020
5. Sonidegib potentiates the cancer cells’ sensitivity to cytostatic agents by functional inhibition of ABCB1 and ABCG2 in vitro and ex vivo;Zhang;Biochem Pharmacol,2022
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The advancement of molybdenum disulfide quantum dots nanoparticles as nanocarrier for drug delivery systems: Cutting-edge in dual therapeutic roles;Journal of Molecular Structure;2024-12
2. Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance;European Journal of Medicinal Chemistry;2024-11
3. AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer;Acta Pharmaceutica Sinica B;2024-09
4. Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition;Molecules;2024-08-23
5. Neighboring Effect‐Initiated Supramolecular Nanocomplex with Sequential Infiltration as Irreversible Apoptosis Inducer for Synergetic Chemo‐Immunotherapy;Advanced Science;2024-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3